miR-155 increases stemness and decitabine resistance in triple-negative breast cancer cells by inhibiting TSPAN5. [electronic resource]
Producer: 20200420Description: 447-461 p. digitalISSN:- 1098-2744
- Antimetabolites, Antineoplastic -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Decitabine -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Humans
- MicroRNAs -- genetics
- Neoplastic Stem Cells -- metabolism
- Signal Transduction -- drug effects
- Tetraspanins -- genetics
- Triple Negative Breast Neoplasms -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.